A report published on Tuesday highlights the frightening extent of sexual harassment in STEM, showing that it remains prevalent and largely unchanged.
Genomic data can have a significant effect on other areas of society. Insurance premiums, familial impact, identification. As we enter the genomic era, policy will need to reflect these new considerations.
Despite the availability of hepatitis C treatment and changes in restrictions of these therapies, private insurance companies and even public payers like Medicaid and Medicare are still refusing to pay for it.
FDA commissioner, Scott Gottlieb said that he expects the FDA to approve 40 gene therapies by 2022 in a fireside chat at the 2018 BIO International Convention.
Some regulatory hurdles for makers of direct-to-consumer genetic health risk test have been lifted by the US Food and Drug Administration.
Whilst biotech companies are rushing to bring transformative gene therapies to market, states are too slow on adopting screening tests for genetic diseases that are, increasingly, treatable.
The Norwegian Academy of Science and Letters, which is one of the world’s richest science awards in the world, have announced its award will go to three discoverers of the genome-editing tool, CRISPR-Cas9.
U.S. regulators have put a halt on a clinical trial planned to use CRISPR technology on sickle-cell patients due to ‘unspecified questions’, CRISPR Therapeutics said on Wednesday.
The FDA is coming down hard on pharma following generic drug stalling tactics. This follows the recent publication from the agency of an online list of pharma companies that together have racked up 150 complaints from generics makers seeking samples.
A great look at the concerns over DIY Gene Editing in The New York Times.
Under the settlement agreement, Oxford Nanopore will refrain from offering its 2D sequencing products in the UK and Germany through the end of 2023.
Much of medicine is about information — the data that helps doctors make the right choices about our treatment. So how will the revolution in big data impact complex healthcare systems like the NHS?